Welcome to Stock Trading Signals

Daily Top Stocks Pick Alert

Hottest Stocks in 2015- ANAC- ZIOP -ADXS- EXEL
Hottest Penny Stocks in 2015 - CTRV -HLTH-FRO
Stocks Pick in 2015 - AAPL - BAC - ANR - X
Hottest Stocks in 2014- AVNR- AGIO -ACH- VDSI
Hottest Penny Stocks in 2014 - JOB -PLUG-QTM
My Daily Trading Activities - Membership Link

Thursday, January 22, 2015

Stock Alerts -(CYTR +2.9%) up on trial results- 1/22/2015

CytRx up on trial results
  • CytRx (CYTR +2.9%) is set for a modest gap up at the open in response to its report of improved overall survival (OS) in a Phase 2b trial assessing aldoxorubicin versus doxorubicin for the treatment of patients with metastatic, locally advanced or unresectable soft tissue sarcomas.
  • In the 123-subject study, the risk of death in the aldoxorubicin cohort was 27% lower than the doxorubicin cohort. Median OS was 16.0 months in the aldoxorubicin group compared to 14.4 months in the doxorubicin group but the results were not statistically significant (p=0.21). In treatment-naive patients, 90% of the study group, median OS for the two cohorts was 16.0 months versus 14.0 months, also falling short of statistical significance (p=0.14).
  • Note: the results were a part of a prospectively planned secondary endpoint analysis and were not powered to demonstrate statistically significant OS.
  • The company will conduct a conference call this morning at 11:00 am ET to discuss the data.
More Stocks News

For the latest updates on the stock market, visit,